Back
Public Service Enterprise Group Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
74
PEG
Public Service Enterprise Group
Last Price:
88.26
Seasonality Move:
2.42%
Sell
35
ALNY
Alnylam Pharmaceuticals
Last Price:
275.08
Seasonality Move:
4.48%
Buy
74
Public Service Enterprise Group (PEG)
is a Buy
Is Public Service Enterprise Group a Buy, Sell or Hold?
- The current Public Service Enterprise Group [PEG] share price is $88.25. The Score for PEG is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- PEG is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $274.91. The Score for ALNY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PEG Stock Price Chart
What is Public Service Enterprise Group's stock price today?
-
The Public Service Enterprise Group share price today is $88.25
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PEG is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $274.91
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight buying pressure.
PEG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.15 | Buy |
Relative Strength Index (14 RSI): | 73.31 | Buy |
Chaikin Money Flow: | 958355 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (80.31 - 86.15) | Buy |
Bollinger Bands (100): | (73.23 - 81.75) | Buy |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.58 | Buy |
Relative Strength Index (14 RSI): | 58.54 | Buy |
Chaikin Money Flow: | 227264 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (257.28 - 277.8) | Buy |
Bollinger Bands (100): | (173.47 - 275.75) | Buy |
PEG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 86.75 | Buy |
20-day SMA: | 83.85 | Buy |
50-day SMA: | 80.91 | Buy |
200-day SMA: | 70.16 | Buy |
8-day EMA: | 86.85 | Buy |
20-day EMA: | 84.64 | Buy |
50-day EMA: | 81.4 | Buy |
200-day EMA: | 72.83 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 273.53 | Buy |
20-day SMA: | 264.94 | Buy |
50-day SMA: | 262.48 | Buy |
200-day SMA: | 194.67 | Buy |
8-day EMA: | 272.54 | Buy |
20-day EMA: | 269.21 | Buy |
50-day EMA: | 257.72 | Buy |
200-day EMA: | 211.82 | Buy |
Public Service Enterprise Group Earnings Growth & PEG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.12 per share, an increase this year of $0.20 per share, and an increase next year of $0.41 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.33 per share, and an increase next year of $0.70 per share.
Public Service Enterprise Group Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |